# Intravenous Magnesium Sulphate Versus Dexmedetomidine for Prevention of Emergence Agitation in Adult Otorhinolaryngologic Surgery

> **NCT07544173** · PHASE4 · COMPLETED · sponsor: **Indonesia University** · enrollment: 64 (actual)

## Conditions studied

- Adults Undergoing Otorhinolaryngology Surgery

## Interventions

- **DRUG:** Magnesium sulphate
- **DRUG:** Dexmedetomidine

## Key facts

- **NCT ID:** NCT07544173
- **Lead sponsor:** Indonesia University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-05-01
- **Primary completion:** 2024-08-31
- **Final completion:** 2025-01-01
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2026-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07544173

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07544173, "Intravenous Magnesium Sulphate Versus Dexmedetomidine for Prevention of Emergence Agitation in Adult Otorhinolaryngologic Surgery". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07544173. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*